Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea
Xuan Che, Jianzhang Wang, Jiayi He, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 2, pp. 224-233
Open Access | Times Cited: 21

Showing 21 citing articles:

Current Medical Therapy for Adenomyosis: From Bench to Bedside
Andrea Etrusco, Fabio Barra, Vito Chiàntera, et al.
Drugs (2023) Vol. 83, Iss. 17, pp. 1595-1611
Open Access | Times Cited: 45
Current and Future Medical Therapies for Adenomyosis
Adela G. Cope, Alessandra J. Ainsworth, Elizabeth A. Stewart
Seminars in Reproductive Medicine (2020) Vol. 38, Iss. 02/03, pp. 151-156
Closed Access | Times Cited: 46
Clinical Utility of Mifepristone: Apprising the Expanding Horizons
Zalak V. Karena, Harsh Shah, Hetvee Vaghela, et al.
Cureus (2022)
Open Access | Times Cited: 22
The Impacts of Inflammatory and Autoimmune Conditions on the Endometrium and Reproductive Outcomes
Isabel Cuadrado-Torroglosa, Juan A. García-Velasco, Diana Alecsandru
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3724-3724
Open Access | Times Cited: 4
Selective progesterone receptor modulators for the treatment of dysmenorrhea: an update
Kubra Ozpinar, Anna Rosa Speciale, Milo Giani, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review
Melinda-Ildiko Mitranovici, Diana Maria Chiorean, Liviu Moraru, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 311-311
Open Access | Times Cited: 3
The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review
Gaby Moawad, Youssef Youssef, Arrigo Fruscalzo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6130-6130
Open Access | Times Cited: 8
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
Monserrat Llaguno‐Munive, Sebastián León-Zetina, Inés Vázquez‐López, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 21
Animal Models of Adenomyosis
Ryan M. Marquardt, Jae‐Wook Jeong, Asgerally T. Fazleabas
Seminars in Reproductive Medicine (2020) Vol. 38, Iss. 02/03, pp. 168-178
Open Access | Times Cited: 21
Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy
Maria Sztachelska, Donata Ponikwicka‐Tyszko, Lydia Martínez-Rodrigo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4407-4407
Open Access | Times Cited: 13
The effects of mifepristone on the structure of human decidua and chorion and Bax and Bcl-2 expression at early stage of pregnancy
Fei Tian, Hua Han, Ligang Jia, et al.
BMC Pharmacology and Toxicology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Effects of Shixiao Huoxue Decoction on pain, tumor necrosis factor-α, and interleukin-8 in patients with adenomyosis
Weihua Li
American Journal of Translational Research (2024) Vol. 16, Iss. 2, pp. 584-591
Open Access | Times Cited: 1
Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis
Hui Zhu, Qimin Ma, Guoling Dong, et al.
International Journal of Hyperthermia (2022) Vol. 40, Iss. 1
Open Access | Times Cited: 7
Magnetic Resonance Imaging‐Based Classification Systems for Informing Better Outcomes of Adenomyosis After Ultrasound‐Guided High‐Intensity Focused Ultrasound Ablating Surgery
Ying Tang, Wenhao Hu, Hang Wang, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 59, Iss. 5, pp. 1787-1797
Closed Access | Times Cited: 3
SFRP4+IGFBP5hi NKT cells induced neural-like cell differentiation to contribute to adenomyosis pain
Yichen Chen, Jue Zhu, Chen Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Knowledge, attitudes, and practices among Chinese reproductive-age women toward uterine adenomyosis
Ruofei Ren, Hongye Li, Jie Zhang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Medical Treatment of Adenomyosis
Bahi Elbasueny, Maya Geerts, Catherine Allaire, et al.
Current Obstetrics and Gynecology Reports (2022) Vol. 11, Iss. 2, pp. 103-117
Closed Access | Times Cited: 2
Investigation of the 12-month efficacy and safety of low-dose mifepristone in the treatment of painful adenomyosis
Shu-Yi Chen, Mengdan Zhao, Wenting Sun, et al.
Reproductive and Developmental Medicine (2022) Vol. 6, Iss. 3, pp. 152-161
Open Access | Times Cited: 1
Medical treatment of adenomyosis: a literature review
V. B. Tskhay, Anna A. Bakunina, Gulnar T. Mikailli
GYNECOLOGY (2023) Vol. 25, Iss. 2, pp. 133-139
Closed Access
АНАЛІЗ КЛІНІКО-АНАМНЕСТИЧНИХ ДАНИХ І ПРЕМОРБІДНОГО ФОНУ ПРИ АДЕНОМІОЗІ
M. O. Scherbyna, Анастасія Олександрівна Чехунова
Актуальні питання педіатрії акушерства та гінекології (2020), Iss. 1, pp. 102-107
Open Access
Identification of an optimal magnetic resonance imaging-based classification for evaluating efficacy of ultrasound-guided high-intensity focused ultrasound
Ying Tang, Jiang Xiao, Ming‐bo Wen, et al.
Authorea (Authorea) (2022)
Open Access
Page 1

Scroll to top